2018
DOI: 10.1038/nrneurol.2018.14
|View full text |Cite|
|
Sign up to set email alerts
|

The current role of MRI in differentiating multiple sclerosis from its imaging mimics

Abstract: MRI red flags proposed over a decade ago by the European Magnetic Resonance Network in MS (MAGNIMS) have guided clinicians in the diagnosis of multiple sclerosis (MS). However, the past 10 years have seen increased recognition that vascular disease can coexist and possibly interact with MS, improvements in the reliability of ways to differentiate MS from novel antibody-mediated CNS disorders (such as anti-aquaporin-4 antibody and myelin-oligodendrocyte glycoprotein antibody-associated diseases) and advances in… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
134
1
3

Year Published

2018
2018
2024
2024

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 180 publications
(140 citation statements)
references
References 174 publications
2
134
1
3
Order By: Relevance
“…Secondly, brain MRI data were not available in this study. NMOSD patients frequently have non‐specific punctate or small patchy lesions in the subcortical or deep white matter; however, symptomatic brain lesions are less frequent compared with MS . Therefore, it is believed that a lack of brain MRI data does not severely reduce the significance of our study results, at least for NMOSD.…”
Section: Discussionmentioning
confidence: 88%
“…Secondly, brain MRI data were not available in this study. NMOSD patients frequently have non‐specific punctate or small patchy lesions in the subcortical or deep white matter; however, symptomatic brain lesions are less frequent compared with MS . Therefore, it is believed that a lack of brain MRI data does not severely reduce the significance of our study results, at least for NMOSD.…”
Section: Discussionmentioning
confidence: 88%
“…MS is a progressive neurodegenerative disease currently assessed using a combination of clinical criteria and findings on MRI (Lublin, ; Geraldes et al, ). MRI evaluation in particular relies on visualization of dissemination in time and space of demyelinating lesions, the presence of which is considered a de facto marker of disease presence rather than a predictor biomarker of disease course (Cahalane et al, ).…”
Section: Discussionmentioning
confidence: 99%
“…However, MRI lesions similar to those found in MS can occur in other disorders, and MRI criteria should not be applied in patients with atypical clinical presentations 6. If there is doubt regarding the nature of symptoms or signs, patients require further evaluation 7.…”
Section: Commentarymentioning
confidence: 99%